- Poster presentation
- Open Access
Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients
© Tsangaris et al. 2011
- Published: 1 March 2011
- Septic Shock
- Secondary Outcome
- Severe Sepsis
- Septic Patient
- Significant Prognostic Factor
Several studies of critically ill patients have suggested an association of the D/D genotype of the insertion/deletion (I/D) angiotensin-converting enzyme (ACE) polymorphism with poor outcome probably by enhancing the inflammatory response and leading to a procoagulant state. Our aim was to evaluate the effect of both the ACE I/D polymorphism and its gene product, on the clinical outcome of critically ill septic patients.
The study cohort included 186 consecutive Caucasian patients with sepsis, severe sepsis or septic shock. Epidemiological, clinical data and co-morbidities along with severity scores were recorded. Measurements of serum ACE activity and genotyping for ACE I/D polymorphism were carried out in all patients. The primary outcomes were the 28-day and 90-day mortalities; secondary outcomes included the number of days without renal or cardiovascular failure, and ventilation-free days over the 28-day period following the study enrollment. One hundred and eighty healthy blood donors were genotyped and used as controls.
Neither the ACE I/D polymorphism nor the serum ACE levels seem to be significant prognostic factors of the outcome of sepsis in critically ill patients.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.